We are live on ! Find out more
GILD icon

Gilead Sciences
GILD

1,564 hedge funds and large institutions have $56.9B invested in Gilead Sciences in 2020 Q4 according to their latest regulatory filings, with 210 funds opening new positions, 520 increasing their positions, 688 reducing their positions, and 164 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 210 | Existing positions closed: 164

2% more funds holding

Funds holding: 1,539 → 1,564 (+25)

0.41% less ownership

Funds ownership: 78.09% → 77.67% (-0.41%)

8% less capital invested

Capital invested by funds: $61.8B → $56.9B (-$4.92B)

16% less call options, than puts

Call options by funds: $1.44B | Put options by funds: $1.72B

22% less funds holding in top 10

Funds holding in top 10: 27 → 21 (-6)

24% less repeat investments, than reductions

Existing positions increased: 520 | Existing positions reduced: 688

Holders
1,564
Holders Change
+25
Holders Change %
+1.62%
% of All Funds
27.67%
Holding in Top 10
21
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-22.22%
% of All Funds
0.37%
New
210
Increased
520
Reduced
688
Closed
164
Calls
$1.44B
Puts
$1.72B
Net Calls
-$272M
Net Calls Change
+$107M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$275M
2
Dodge & Cox
Dodge & Cox
California
+$272M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$155M
4
AAMU
Amundi Asset Management US
Massachusetts
+$112M
5
Millennium Management
Millennium Management
New York
+$110M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$398M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$239M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$158M
4
AIG
American International Group
New York
-$131M
5
Bank of America
Bank of America
North Carolina
-$122M
Name Holding Trade Value Shares
Change 		Change in
Stake
NA
1601
Navellier & Associates
Nevada
– -$1.21M -19,196 Closed
BO
1602
BRR OpCo
Ohio
– -$1.14M -18,064 Closed
BA
1603
Bristlecone Advisors
Washington
– -$1.08M -17,124 Closed
SC
1604
Stolper & Co
Oklahoma
– -$1.04M -16,496 Closed
TC
1605
Toews Corporation
New Jersey
– -$973K -15,400 Closed
JSL
1606
JT Stratford LLC
Georgia
– -$921K -14,571 Closed
LFM
1607
Lumina Fund Management
New York
– -$916K -14,500 Closed
DA
1608
Duality Advisers
Florida
– -$915K -14,480 Closed
BMO
1609
Beck Mack & Oliver
New York
– -$836K -13,235 Closed
HT
1610
HighTower Trust
Texas
– -$768K -12,158 Closed
HIM
1611
Hotaling Investment Management
Pennsylvania
– -$767K -12,139 Closed
BPGAM
1612
BTG Pactual Global Asset Management
Bermuda
– -$754K -11,940 Closed
GAM
1613
Grandview Asset Management
Pennsylvania
– -$714K -11,300 Closed
RG
1614
Renaissance Group
Kentucky
– -$700K -11,080 Closed
VF
1615
Virtu Financial
New York
– -$679K -10,741 Closed
LOAMU
1616
Lombard Odier Asset Management (USA)
New York
– -$625K -10,366 Closed
SCP
1617
Seizert Capital Partners
Michigan
– -$644K -10,184 Closed
BAM
1618
Beaumont Asset Management
Texas
– -$632K -10,001 Closed
TAL
1619
TIG Advisors LLC
New York
– -$631K -9,992 Closed
MTIM
1620
Marathon Trading Investment Management
Pennsylvania
– -$579K -9,600 Closed
AL
1621
Aspiriant LLC
California
– -$602K -9,516 Closed
AMG
1622
Asset Management Group
Connecticut
– -$592K -9,368 Closed
BS
1623
Banco Santander
Spain
– -$588K -9,298 Closed
GCP
1624
GSA Capital Partners
United Kingdom
– -$570K -9,014 Closed
SL
1625
Stevard LLC
Illinois
– -$562K -8,900 Closed
63 64
65
66 67

GILD Hedge Fund Activity: Q4 2020 in Review

1,564 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2020, worth a combined $56.9B — down 8% from $61.8B a quarter earlier.

Buyers outnumbered sellers: 210 funds opened new GILD positions and 164 closed out — a net gain of 46 holders — while 520 added to existing stakes and 688 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $275M. The largest seller was BlackRock, cutting an estimated $398M.

  • 1,564 institutional investors held Gilead Sciences (GILD) as of Q4 2020, up from 1,539 in Q3 2020.
  • Funds reported $56.9B of Gilead Sciences stock for Q4 2020, down 8% quarter-over-quarter.
  • 210 funds opened new Gilead Sciences positions in Q4 2020 and 164 closed out, a net change of +46 holders.
  • The largest Gilead Sciences buyer in Q4 2020 was Capital Research Global Investors, an estimated $275M added.
  • The largest Gilead Sciences seller in Q4 2020 was BlackRock, an estimated $398M sold.

Based on aggregated 13F filings for Q4 2020.